SCHEMBL24492782

SCHEMBL24492782

c1ccc(-n2c3ccccc3c3cc(-c4cc(-c5cccc(-c6cccc(-c7cncnc7)n6)c5)cc(-c5cccc(-c6cccc(-c7cncnc7)n6)c5)c4)ccc32)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ATM Q13315 2/20 0.42
▸ L3MBTL1 Q9Y468 2/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ PTGER4 P35408 1/20 0.35
▸ NPY5R Q15761 2/20 0.35
▸ KMT2A Q03164 3/20 0.34
▸ MEN1 O00255 2/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ HDAC8 Q9BY41 2/20 0.33
▸ CYP19A1 P11511 1/20 0.33
▸ PIM1 P11309 1/20 0.33
▸ MAPT P10636 2/20 0.32
▸ TSPO P30536 1/20 0.32
▸ IL1R1 P14778 1/20 0.32
▸ USP2 O75604 3/20 0.32
▸ CYP1A2 P05177 3/20 0.32
▸ CYP2C9 P11712 3/20 0.32
▸ CYP2C19 P33261 3/20 0.32
▸ CYP3A4 P08684 2/20 0.32
▸ TSHR P16473 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24493239 0.90 ATM (0.49) ATML3MBTL1KDM4EPTGER4NPY5R
SCHEMBL24493048 0.90 CYP19A1 (0.36) ATMKMT2AMEN1RAB9AHDAC8
SCHEMBL24492872 0.89 ATM (0.37) ATML3MBTL1KDM4EKMT2AMEN1
SCHEMBL24492899 0.88 ATM (0.46) ATML3MBTL1KDM4EPTGER4NPY5R
SCHEMBL19762210 0.88 L3MBTL1 (0.51) ATML3MBTL1KDM4EPTGER4NPY5R
SCHEMBL24492784 0.87 KDM4E (0.43) ATML3MBTL1KDM4EPTGER4NPY5R
SCHEMBL17253686 0.87 L3MBTL1 (0.47) ATML3MBTL1KDM4EPTGER4NPY5R
SCHEMBL17228139 0.86 L3MBTL1 (0.56) ATML3MBTL1KDM4EPTGER4NPY5R
SCHEMBL23843598 0.85 CYP19A1 (0.48) ATML3MBTL1KDM4ECYP19A1MAPT
SCHEMBL4546991 0.85 L3MBTL1 (0.49) ATML3MBTL1KDM4EPTGER4NPY5R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220177454-A1 TRISUBSTITUTED BENZENE COMPOUND HAVING NITROGEN-CONTAINING HETERO RING IN MOLECULAR TERMINUS AND ORGANIC ELECTROLUMINESCENCE ELEMENT HODOGAYA CHEMICAL CO., LTD. (JP) 2022-06-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220177454-A1 TRISUBSTITUTED BENZENE COMPOUND HAVING NITROGEN-CONTAINING HETERO RING IN MOLECULAR TERMINUS AND ORGANIC ELECTROLUMINESCENCE ELEMENT ETV6, LEF1, TEAD2 ATM 3566/4885L3MBTL1 1418/4885KDM4E 688/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback